Metraipolis › archive › dc_d67d05bf7349

A real-world disproportionality analysis of sacubitril/valsartan: data mining of the FDA adverse event reporting system — Europe PMC PMID:39193332

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/39193332
DOI
10.3389/fphar.2024.1392263
License (as archived)
solo-consultazione
Archived
2026-10-08T02:42:42.257Z
SHA-256 of the archived text
c35a937147c109258707711850dbc554c075bd3adcc8560bb65334a17703932a
Stable URL of this page
https://metraipolis.com/documento/dc_d67d05bf7349

How to cite

A real-world disproportionality analysis of sacubitril/valsartan: data mining of the FDA adverse event reporting system — Europe PMC PMID:39193332 — Europe PMC (en), https://europepmc.org/article/MED/39193332 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_d67d05bf7349 (Metraipolis archive dc_d67d05bf7349, sha256 c35a937147c109258707711850dbc554c075bd3adcc8560bb65334a17703932a)
BibTeX
@misc{dcd67d05bf7349,
  title = {A real-world disproportionality analysis of sacubitril/valsartan: data mining of the FDA adverse event reporting system — Europe PMC PMID:39193332},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/39193332},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_d67d05bf7349; sha256 c35a937147c109258707711850dbc554c075bd3adcc8560bb65334a17703932a},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/39193332. Agents can read the archived copy with the MCP tool read_document.